BioInsights - Advances in AAV process development

Advances in AAV process development

Cell & Gene Therapy Insights 2022; 8(1), 59

10.18609/cgti.2022.030

Published: 14 February 2022
ALEJANDRO BECERRA, Matthias Hebben, Michael Mercaldi

Cell & Gene Therapy Insights and Thermo Fisher Scientific brought together a panel of experts to discuss how viral vector manufacture has evolved over the past 2 years, the challenges created by the pandemic, and what we can expect in the future.

You can view or download the poster here.

If you are interested in learning more, you can read the interview or watch to the full roundtable here.